Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Alzheimer’s Breakthrough: Why the Experts are Betting on NervGen

It's the disease that most of us regard with the greatest dread – especially since nearly one in every three people will eventually be afflicted. This is why a breakthrough pharmaceutical drug for Alzheimer’s disease would not only be a godsend to society,...
Marc Davis | April 7, 2021 |

Titans in Mining: An Interview with Rick Rule, Part I

The Critical Investor sits down with Rick Rule, CEO of Sprott U.S. Holdings, for a wide-ranging discussion of his more than four-decade-long involvement in the resource sector. Several months ago I thought of something different. Wouldn't it be nice to interview the...
Streetwise Reports | January 17, 2020 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Why the US is Backing American Lithium

It’s a strategically symbolic investment that clearly demonstrates the US government’s determination to break China’s dominance of the global lithium trade. Now that lithium has been declared as critical to America&CloseCurly...
Marc Davis | April 29, 2021 |

Sierra Madre Gold & Silver: Mining’s Next Star Performer?

As the US economy bounces back, confident and emboldened investors are rushing back into speculative stocks and cryptocurrencies (like Bitcoin) with a view to making outsized financial gains. Lately, it’s been a dominant media...
Marc Davis | April 27, 2021 |

Big Picture Outlook: Seat Belts Tightened

"Gold is money; everything else is credit." —J.P. Morgan Dating back to the mid-80s, and usually around the end of November, I begin to formulate strategies and portfolios looking out to the upcoming New Year, taking into account technical, fundamental and geopolitica...
Streetwise Reports | December 3, 2019 |

Equity Metals focuses on discovery in British Columbia

Equity Metals Corp. (TSXV:EQTY) is a Canada-based mineral exploration company. The company owns 100 per cent interest, with no underlying royalties, in its flagship Silver Queen Project along the Skeena Arch in the Omineca Mining Division in British Columbia. Equ...
Coreena Robertson | September 19, 2023 |

Exploration company provides project portfolio update

The following is a transcription of the above video, and The Market Online has edited it for clarity . Banyan Gold Corp. (TSXV:BYN) is focused on exploration and advancing and de-risking its 7-million-ounce AurMac Gold Project in the Yukon, Canada&CloseCurlyQ...
Ryan Dhillon | April 25, 2024 |

Getchell Wins the Nevada Lotto

In every precious metals cycle there comes a time where a company has good assets but for one reason or another has failed to garner traction and has to pretty much give away projects. That point came for Canarc (CCM-V) last year. They pretty much gave away a high-grade g...
Streetwise Reports | February 3, 2020 |
1 2 3 4 5 6 7 8 9 10 ...